|
Volumn 82, Issue 6, 2013, Pages 353-354
|
Benzodiazepines revisited
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CHLORDIAZEPOXIDE;
DIAZEPAM;
FLUOXETINE;
NEUROLEPTIC AGENT;
SEROTONIN UPTAKE INHIBITOR;
AGORAPHOBIA;
ALCOHOL WITHDRAWAL;
ANXIETY DISORDER;
CLINICAL PRACTICE;
DRUG ABUSE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG SAFETY;
DYSPHORIA;
EDITORIAL;
EVIDENCE BASED MEDICINE;
GENERALIZED ANXIETY DISORDER;
HUMAN;
MANIA;
PANIC;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SEIZURE;
SEXUAL DYSFUNCTION;
SLEEP DISORDER;
TRANQUILIZING ACTIVITY;
ACUTE TOXICITY;
CAR DRIVING;
CHRONIC TOXICITY;
DRUG DEPENDENCE;
DRUG INDUSTRY;
SELF MEDICATION;
TREATMENT INDICATION;
ANTI-ANXIETY AGENTS;
ANXIETY DISORDERS;
BENZODIAZEPINES;
HUMANS;
|
EID: 84886254183
PISSN: 00333190
EISSN: 14230348
Source Type: Journal
DOI: 10.1159/000353599 Document Type: Editorial |
Times cited : (16)
|
References (4)
|